SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-19-000046
Filing Date
2019-03-06
Accepted
2019-03-06 16:06:06
Documents
2
Period of Report
2019-03-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xk_030619.htm 8-K 24084
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 148559
  Complete submission text file 0000886163-19-000046.txt   173799
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 19662569
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences